ALXN - Alexion Might Finally Satisfy The Market

Alexion Pharmaceuticals (ALXN) is up over 30% this year, but due to a dip at the end of 2018, the stock isn't in uncharted territory. Current investors may be frustrated with what amounts to volatile but nonetheless sideways trading and considering if 2019 will offer anything different. This article takes a look at the story around ALXN and considers if a change is coming in 2019.

Data by YCharts

Figure 1: Past 3 years of ALXN trading.

ALXN needed to strengthen its pipeline

Back in early 2018, ALXN had a pipeline made largely

Read more ...